Subscribe to RSS - Home Solutions

Home Solutions

BioScrip, Home Solutions tweak deal


DENVER – The price tag for BioScrip’s acquisition of Home Solutions has dropped from $85 million to $75 million, according to news reports.

BioScrip completes offering


DENVER – BioScrip has completed a public offering of common stock, netting approximately $83.15 million.

Greenleaf: 'Home infusion is a valuable option'


In his six years in the home infusion business, Dan Greenleaf has seen his share of challenges. Still, the new CEO of Home Solutions says it’s an exciting place to be. He spoke with HME News recently about home infusion’s role in the “medical neighborhood.”

Former Apria exec moves to new post


DENVER – Daniel Greenleaf is now president and CEO of specialty-infusion company Home Solutions, the Denver Post reports.